Application Note

Lipid Nanoparticle Compositional Analysis By UHPLC-CAD

Lipid Nanoparticle mRNA Vaccine GettyImages-1418152448

In vitro transcribed messenger ribonucleic acid (mRNA) has emerged as a novel therapeutic platform. Lipid nanoparticles (LNPs) facilitate the effective delivery of mRNA to specific cell types and tissues, whilst enhancing stability. The efficacy, biodistribution, and potential toxicity of the therapeutic are determined in large part by the lipid composition of the LNP. Accordingly, the identity, quantity, and purity of the individual lipids are critical quality attributes of mRNA-LNP products.

Ultra-high performance liquid chromatography (UHPLC) coupled with Charged Aerosol Detection (CAD) is a powerful technique for the analysis of compounds, such as lipids, that do not contain chromophores. Explore results generated from an internal study using UHPLC-CAD and a proprietary mRNA-LNP formulation.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development